期刊
CURRENT ONCOLOGY
卷 29, 期 6, 页码 4068-4080出版社
MDPI
DOI: 10.3390/curroncol29060324
关键词
giant cell tumor of bone; malignancy in giant cell tumor; secondary malignancy; malignant transformation; radiotherapy; recurrence; prognosis
类别
In this study, we reviewed the clinicopathological characteristics and prognosis of 12 MGCT patients and found that the median latency to malignant transformation was 63 months, with five-year overall recurrence and metastasis-free survival rates of 61.9%, 66.7%, and 58.3%, respectively. Initial metastasis and benign local recurrence of GCTB were both negative prognostic factors.
Giant cell tumor of bone (GCTB) undergoes a sarcomatous transformation. Secondary malignancy in giant cell tumor (MGCT) is associated with radiotherapy and has a dismal prognosis. We reviewed medical records to investigate the clinicopathological characteristics and prognosis of MGCT patients. The enrollment criterion was high-grade spindle-cell sarcoma, which developed at the site of prior GCTB treatment. Twelve patients were analyzed: six females and six males. The median age was 42.5 years. Benign recurrence occurred in five GCTB patients not treated with radiotherapy. No pulmonary implants were observed. The median latency to the malignant transformation was 63 months. Nine patients were AJCC stage IIB, and three were stage IVA. The median follow-up period after malignant transformation was 62.5 months. Five patients developed local recurrence, and six had distant metastasis. Five-year overall recurrence and metastasis-free survival rates were 61.9%, 66.7%, and 58.3%, respectively. Initial metastasis was a predictive factor for overall survival. Benign local recurrence of GCTB was also a negative factor for metastasis-free survival of MGCT patients. Differences in overall survival according to benign recurrence also showed a tendency toward significance. In our series, secondary MGCT did not occur after radiotherapy. The prognosis was better than previous findings. Benign recurrence of GCTB could reflect the prognosis of MGCT.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据